Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Prednisone should be tapered gradually under a doctor's guidance, never stopped abruptly, because long-term use suppresses your adrenal glands' natural cortisol production. Typical plans reduce the dose in small steps every few days to a few weeks, with slower tapers for higher doses, longer treatment courses, or when withdrawal symptoms like fatigue, body aches, nausea, joint pain, dizziness, or low mood appear. Your taper speed also depends on the condition being treated, since flares can occur if the dose drops too quickly, and several other factors matter as well, so review the complete details below before changing anything.
If you are unsure whether what you feel is steroid withdrawal, a returning flare, or something unrelated, guessing can delay care you may need. A free, instant, online symptom check takes only a few minutes, helps you organize what you are experiencing, and points you toward the right next step and the right questions for your prescriber.
Last reviewed for medical accuracy: 09/24/2026
Prednisone is a powerful corticosteroid used to control inflammation and suppress the immune system in conditions like asthma, rheumatoid arthritis, lupus and more. While it can be lifesaving, stopping prednisone suddenly after weeks or months of use can lead to serious withdrawal symptoms and adrenal insufficiency. This guide will help you understand why a gradual taper is crucial, outline general tapering strategies, and answer common questions—like “can I drink alcohol while taking prednisone 20 mg?”—so you can come off prednisone safely under medical supervision.
Adrenal suppression
Long-term prednisone tricks your body into thinking it makes enough cortisol, so your adrenal glands slow or stop production. If you stop prednisone abruptly, you may not have enough cortisol to handle daily stress or illness.
Risk of withdrawal
Symptoms of steroid withdrawal include:
Preventing adrenal crisis
In rare cases, sudden prednisone discontinuation can trigger an adrenal crisis—a life-threatening drop in blood pressure and blood sugar. A gradual taper lets your adrenal glands “wake up” and start producing cortisol again.
Each taper should be personalized by your prescribing doctor, based on:
Initial dose
Higher doses (e.g., > 20 mg daily) often require a slower taper.
Duration of therapy
The longer you’ve been on prednisone, the slower the taper must be.
Underlying condition
Active inflammation or autoimmune disease may flare if you taper too quickly.
Individual response
Everyone reacts differently. Some people need extra time at certain dose levels before stepping down further.
Below is a framework that many clinicians follow. Always consult your healthcare provider for a plan tailored to you.
High-dose phase (> 20 mg daily)
Mid-dose phase (10–20 mg daily)
Low-dose phase (< 10 mg daily)
Very low-dose phase (< 5 mg daily)
Return of original symptoms
Joint pain, rashes, breathing issues or other underlying condition flares.
Withdrawal signs
Fatigue, dizziness, nausea, muscle or joint aches.
If these occur, pause the taper or increase by the last dose reduction and discuss with your doctor.
Vital signs
Periodic blood pressure checks—especially if you feel lightheaded when standing.
Lab tests
Your doctor may check cortisol levels or inflammatory markers to guide the taper.
Supporting your body can ease the transition off prednisone.
Nutrition
Exercise
Stress management
Sleep and rest
Many people wonder about alcohol use while on prednisone, especially at a moderate dose like 20 mg daily:
Moderation is key
Occasional, light drinking (1 drink for women, up to 2 for men) is unlikely to cause major problems for most healthy adults.
Potential risks
When to be extra cautious
Practical tips
As you taper, stay alert to changes in how you feel. If anything feels off:
Use a free, online symptom check, using the doctor approved Ubie Symptom Checker to track early warning signs and get guidance at ubiehealth.com.
Keep a daily journal of:
Share your journal at every follow-up appointment so your provider can adjust your taper if needed.
While many mild withdrawal symptoms can be managed with a slower taper, seek immediate medical attention if you experience:
These could indicate serious complications or life-threatening issues.
Always remember that your prescribing physician knows your medical history best. Speak to a doctor about any concerns—especially if you suspect serious side effects or complications. Your health and safety come first.
(References)
* Prussick R, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol. 1996 Aug;35(2 Pt 2):346-9. doi: 10.1016/s0190-9622(96)90667-2. PMID: 8698924.
* Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849. PMID: 28745999.
* Jayne DRW, Merkel PA, Schall TJ, Bekker P, ADVOCATE Study Group. Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. PMID: 33596356.
* Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B, SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. PMID: 37792612.
* De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica. Ann Rheum Dis. 2024 Feb 15;83(3):335-341. doi: 10.1136/ard-2023-224768. Epub 2024 Feb 15. PMID: 37932008.
* Gawrieh S, Dasarathy S, Tu W, Kamath PS, Chalasani NP, McClain CJ, Bataller R, Szabo G, Tang Q, Radaeva S, Barton B, Nagy LE, Shah VH, Sanyal AJ, Mitchell MC, AlcHepNet Investigators. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis. J Hepatol. 2024 May;80(5):684-693. doi: 10.1016/j.jhep.2024.01.031. Epub 2024 Feb 10. PMID: 38342441; PMCID: PMC11214682.
* Cai L, Li G, Abdulaziz AT, Gong X, Liu X, Kong X, Guo K, Li A, Li J, Zhou D, Hong Z. Efficacy and safety of different oral prednisone tapering courses in adult anti-NMDAR encephalitis: A multicenter prospective cohort study. Epilepsia. 2024 Nov;65(11):3199-3215. doi: 10.1111/epi.18107. Epub 2024 Sep 26. PMID: 39324872.
* Wang R, Lin Q, Sheng L, Zhang Y, Wen H, Li Y, Shi M, Xiao X, Yan L, Guo C, Miao Q, Hua J, Huang Z, Li H, Gershwin ME, Wang Q, Ma X, Lian M. Optimizing the tapering scheme of corticosteroid treatment for acute onset of autoimmune hepatitis. J Autoimmun. 2025 Mar;152:103387. doi: 10.1016/j.jaut.2025.103387. Epub 2025 Feb 26. PMID: 40015068.
* Adalimumab versus Conventional Immunosuppression for Uveitis Trial Research Group, Jabs DA, Sugar EA, Burke AE, Altaweel M, Thorne JE, Baksh S, Lim L, Thomas A, Yeh S, Holbrook JT. Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial. Ophthalmology. 2026 Mar;133(3):310-325. doi: 10.1016/j.ophtha.2025.10.004. Epub 2025 Oct 11. PMID: 41077357; PMCID: PMC13001625.
* Stone JH, Buttgereit F, Saraux A, Schmidt WA, Dejaco C, Spiera R, Dasgupta B, Drescher E, Jordan A, Novosad L, Nakagomi D, Koyama Y, Duran-Barragan S, Tracey G, Ruyssen-Witrand A, Rubbert Roth A, Fang J, Ng J, Hiremath R, Raffner R, Martin R, Napoletano S, Huang S, Storim J, Patekar M, REPLENISH Investigators. Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica. N Engl J Med. 2026 Aug 13;395(7):637-647. doi: 10.1056/NEJMoa2602567. Epub 2026 Jun 3. PMID: 42234540.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.